{"entity":{"id":"nct00703820","kind":"trial","name":"Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia","aka":[],"tldr":"A phase 3 trial of Cytarabine, Daunorubicin, Etoposide and Clofarabine in Acute myeloid leukaemia, run by St. Jude Children's Research Hospital, completed.","summary":"Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia is a phase 3 interventional study registered as NCT00703820 by St. Jude Children's Research Hospital, with 324 participants recorded, started 2008-08-04 and reaching its primary completion in 2017-03-30. Interventions recorded: Cytarabine, Daunorubicin, Etoposide, Clofarabine, CliniMACS. Conditions recorded: Acute Myeloid Leukemia.\n\nLinked to the drug Clofarabine because the registry names it among its interventions and Acute myeloid leukaemia among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00703820","url":"https://clinicaltrials.gov/study/NCT00703820"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["aml"],"sections":[],"technologies":[],"targets":[],"drugs":["cytarabine","daunorubicin","etoposide","clofarabine"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00703820","phase":"3","setting":"AML08: A Phase II Randomized Trial of Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Phase II Study Of Natural Killer Cell Transplantation In Patients With Newly Diagnosed Acute Myeloid Leukemia","sponsor":"St. Jude Children's Research Hospital","participation":[{"nct":"NCT00703820","source":"https://clinicaltrials.gov/study/NCT00703820","fetchedAt":"2026-10-07T16:52:11.535Z","studySha256":"fa789338a1deabc70817aefe582dafe5e70b1c82ff0d8e4362d8f2e03ac51d55","overallStatus":"COMPLETED","lastUpdatePosted":"2021-08-10","leadSponsor":"St. Jude Children's Research Hospital","collaboratorCount":2,"maximumAge":"21 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":324,"enrolmentType":"ACTUAL","siteCount":8,"recruitingSiteCount":0,"countries":["Singapore","United States"]}],"started":"2008-08-04","startedType":"actual","enrolled":324,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00703820/","neighbours":{"cancer":[{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"}],"drug":[{"id":"clofarabine","kind":"drug","name":"Clofarabine","route":"/drugs/clofarabine/"},{"id":"cytarabine","kind":"drug","name":"Cytarabine","route":"/drugs/cytarabine/"},{"id":"daunorubicin","kind":"drug","name":"Daunorubicin","route":"/drugs/daunorubicin/"},{"id":"etoposide","kind":"drug","name":"Etoposide","route":"/drugs/etoposide/"}]}}